Hepatitis B Hinders Response to Treatment in Rheumatoid Arthritis

June 6, 2018
Gregory M. Weiss, MD

Consider screening patients with RA for HBV exposure/infection as a part of the pretreatment assessment.

Reference1. Chen YL, Lin JZ, Mo YQ, et al. Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study. Arthritis Res Ther. 2018;20:81. doi: 10.1186/s13075-018-1548-5.

Related Content:

Rheumatoid Arthritis